This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

McCann Health Announces Major Leadership Promotions For North American Management

PARSIPPANY, N.J. and NEW YORK, June 26, 2013 /PRNewswire/ -- In a series of major moves aimed at bolstering the capabilities of its North American operations, John Cahill , Global CEO of McCann Health, announced the promotion of Marci Piasecki to Regional Director of McCann Health North America. Previously, Piasecki was CEO of McCann Torre Lazur Group. Her new regional management responsibilities include overseeing McCann Torre Lazur, McCann Echo Torre Lazur, McCann Regan Campbell Ward, McCann RCW Healthcare, and McCann Managed Markets. This is a new position. Other leadership changes include:
  • Bill McEllen has been promoted to President of McCann Torre Lazur Group, overseeing McCann Torre Lazur and McCann Echo Torre Lazur. McEllen had been President of Echo Torre Lazur.
  • Succeeding McEllen as President of McCann Echo Torre Lazur is Sonja Foster-Storch , formerly Managing Director of CDM Princeton.
  • Maureen Regan will retain her leadership role at McCann Regan Campbell Ward Group (consisting of McCann Regan Campbell Ward and McCann RCW Healthcare) as President, while Brendan Ward evolves in to a complex science role for the agency and Richard Campbell retains his role as head of Planning.
  • Kim Wishnow-Per has been named President of McCann Managed Markets, previously known as McCann Torre Lazur Managed Markets; Kim and the managed markets agency now partner across all McCann Health U.S. agencies under the same governance

Said John Cahill, "Marci is an extraordinary leader and pillar of McCann Health.  Year after year,  whatever the business environment, Marci has proven herself again and again by growing her business through her exemplary capabilities and by attracting and retaining remarkably talented staff and roster of clients."

Said Marci Piasecki, "I am honored and eager to assume this new level of leadership within McCann Health. Equally importantly, I am excited for my colleagues who have worked along-side me to provide our network with their expanded responsibilities."

With 25 years in the industry and an outstanding ability to recognise and nurture agency talent, Piasecki's unique, motivational mentoring fosters the forward thinking and creative ideas to help propel brands to success. Piasecki leverages her branding experience in the fields of oncology, neurology, cardiology and vaccines. Her flagship agency, McCann Torre Lazur, has won the coveted MedAd News' Manny Medical Advertising Agency of the Year Award 6 times. Piasecki has also been personally recognised by PharmaVoice as one of industry's "Most Inspiring People."

About McCann Health : Comprising the world's most connected health and wellness experts, McCann Health is the most awarded professional and consumer health communications network with the largest international expertise spanning 35 countries and 57 offices. McCann Health's global network includes McCann Healthcare, McCann HumanCare,  McCann Regan Campbell Ward, McCann Torre Lazur, McCann Complete Medical, the leading worldwide medical communications practice, as well as Double Helix, an international healthcare consultancy focused on working with clients on strategic market research and market access issues. McCann Health is a part of McCann Worldgroup, the largest marketing communications agency network in the world, and is a leading healthcare agency network owned by Interpublic Group [NYSE: IPG].

McCann Worldgroup , part of Interpublic Group (NYSE: IPG), is a leading global marketing company with 23,000 employees in more than 120 countries comprising McCann Erickson (advertising), MRM (digital marketing/relationship management), Momentum (event marketing/promotion), McCann Health (professional/dtc communications), CRAFT (global adaptation and production), UM (media management), Weber Shandwick (public relations), and FutureBrand (consulting/design).

SOURCE McCann Health

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.24 -0.41%
FB $117.81 -0.21%
GOOG $701.43 0.82%
TSLA $211.53 -4.96%
YHOO $36.94 2.61%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs